Ansell on condom labels
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed warnings for condoms employing the spermicide nonoxynol-9 are "alarmist and unwarranted" because "there are no studies linking N-9 condoms to vaginal irritation and increased transmission of HIV," Ansell Healthcare Products states in Feb. 10 comments to the agency. N-9 studies that have shown an increased transmission of HIV "involved different vehicles (gels and suppositories) as well as dramatically higher doses (50 mg-150 mg vs. < 32 mg)" than is typical of N-9 condoms, the LifeStyles manufacturer adds. The agency proposed label warnings in November which would state that N-9 can increase the risk of getting HIV/AIDS from an infected partner if used regularly (1"The Tan Sheet" Nov. 21, 2005, p. 13). Ansell also objects to including in labeling a table comparing various contraceptive methods because it contains "Typical Use" rates, which are "not based on scientifically valid data."...
You may also be interested in...
Latex Condom Labels Would Bear N-9, STD Warnings Under FDA Proposal
Labeling for condoms that employ nonoxynol-9 should be amended to state that spermicidal lubricants may increase HIV transmission, FDA says in a proposed rule published in the Federal Register Nov. 14
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.